Cargando…

Bromocriptine or cabergoline-induced cerebrospinal fluid rhinorrhea: A life-threatening complication during management of prolactinoma

Detalles Bibliográficos
Autores principales:	Singh, Pratibha, Singh, Manish, Cugati, Goutham, Singh, Ajai Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205534/ https://www.ncbi.nlm.nih.gov/pubmed/22065735 http://dx.doi.org/10.4103/0974-1208.86096

Ejemplares similares

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
por: Singh, Pratibha, et al.
Publicado: (2011)

Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
por: Menon, Lakshmi P., et al.
Publicado: (2021)

Limited unilateral partial laminectomy and lateral dural incision: One of the best approaches for spinal meningioma in selected cases
por: Singh, Manish, et al.
Publicado: (2012)

Effect of epilepsy on female fertility and reproductive abnormalities
por: Singh, Pratibha, et al.
Publicado: (2011)

Hyperprolactinemia: An often missed cause of male infertility
por: Singh, Pratibha, et al.
Publicado: (2011)

Programmable morphine pump (an intrathecal drug delivery system) – A promising option for pain relief and palliation in cancer patients
por: Singh, Manish, et al.
Publicado: (2012)

Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma
por: Kim, Hae-Kyung, et al.
Publicado: (2021)

Fingolimod: The first oral drug approved by food and drug administration; A breakthrough in treatment of multiple sclerosis
por: Singh, Manish, et al.
Publicado: (2011)

Cabergoline-Induced Pneumocephalus Following Treatment for Giant Invasive Macroprolactinoma Presenting With Spontaneous Cerebrospinal Fluid Rhinorrhea
por: Elabd, Souha S, et al.
Publicado: (2018)

Cerebrospinal fluid rhinorrhea
por: Mohanty, Aaron
Publicado: (2016)

Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively
por: Tang, Chao, et al.
Publicado: (2019)

Endoscopic management of cerebrospinal fluid rhinorrhea
por: Yadav, Yad Ram, et al.
Publicado: (2016)

Endoscopic repair of cerebrospinal fluid rhinorrhea()
por: Kljajić, Vladimir, et al.
Publicado: (2016)

Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014)

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995)

The Endonasal Endoscopic Management of Cerebrospinal Fluid Rhinorrhea
por: Bubshait, Rawan F, et al.
Publicado: (2021)

Spontaneous reduction of prolactinoma post cabergoline withdrawal
por: Venkatesh, Sampath Kumar, et al.
Publicado: (2012)

Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline
por: Ghadirian, Hesam, et al.
Publicado: (2018)

Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy
por: Bajwa, Sukhwinder Kaur, et al.
Publicado: (2011)

Cerebrospinal fluid rhinorrhea: An institutional perspective from Pakistan
por: Tahir, Muhammad Zubair, et al.
Publicado: (2011)

Non-traumatic cerebrospinal fluid rhinorrhea: diagnosis and management
por: Al-Sebeih, Khalid, et al.
Publicado: (2004)

Spontaneous Cerebrospinal Fluid Rhinorrhea: A Case Report
por: Boppana, Hemanth Krishna, et al.
Publicado: (2020)

Zipline Into a Case of Spontaneous Cerebrospinal Fluid Rhinorrhea
por: Haseeb, Shahan, et al.
Publicado: (2021)

Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline
por: Pala, Nazir A., et al.
Publicado: (2015)

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
por: Khare, Shruti, et al.
Publicado: (2017)

Neuropsychiatric Effects in Patients With Invasive Prolactinomas Treated With Cabergoline
por: Calva-González, Metztli, et al.
Publicado: (2023)

Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma
por: Hayes, Annabelle G, et al.
Publicado: (2022)

Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
por: Cho, Kyung Rae, et al.
Publicado: (2013)

Cerebrospinal Fluid Rhinorrhea and Seizure Caused by Temporo-Sphenoidal Encephalocele
por: Hammer, Alexander, et al.
Publicado: (2015)

Spontaneous cerebrospinal fluid rhinorrhea: A case report and analysis
por: Chen, Guang Yong, et al.
Publicado: (2018)

RE: Non-traumatic cerebrospinal fluid rhinorrhea: diagnosis and management
por: Dorta-Contreras, Alberto
Publicado: (2005)

A Rare Case of Spontaneous Recurrent Cerebrospinal Fluid Rhinorrhea
por: Wang, Wen, et al.
Publicado: (2019)

Spontaneous Cerebrospinal Fluid Rhinorrhea in End Stage Renal Disease
por: Jyothsna, Balachandran P., et al.
Publicado: (2021)

Diagnosis and Localization of Cerebrospinal Fluid Rhinorrhea: A Systematic Review
por: Xie, Michael, et al.
Publicado: (2021)

Spontaneous Cerebrospinal Fluid Rhinorrhea Secondary to Idiopathic Intracranial Hypertension
por: Ali, Mohamed, et al.
Publicado: (2023)

Frontal Meningoencephalocele With Cerebrospinal Fluid Rhinorrhea: A Case Report
por: AlEnezi, Abdulaziz Y, et al.
Publicado: (2023)

Evaluation of atherosclerosis after cessation of cabergoline therapy in patients with prolactinoma
por: Doğan, Berçem Ayçiçek, et al.
Publicado: (2016)

Cabergoline treatment in prolactinoma: Amelioration in obstructive and central sleep apneas
por: Binar, M, et al.
Publicado: (2019)

Abstract 94: Efficacy of cabergoline treatment in men with giant prolactinomas
Publicado: (2022)

Rapid reduction with cystic transformation of invasive giant prolactinoma following short term low dose cabergoline
por: Dutta, Deep, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_74a9rcjhrdgasbrm27h6u0mm3v